Literature DB >> 32758727

Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice.

Daojuan Wang1, Yajing Weng1, Yaling Zhang1, Rong Wang1, Tingyu Wang1, Jianjun Zhou2, Shanmei Shen2, Hongwei Wang1, Yong Wang3.   

Abstract

Hyperandrogenism is the main cause of infertility as a result of polycystic ovary syndrome (PCOS). Long-term and continuous exposure to hyperandrogen can cause follicular developmental disorders. Ovarian granulosa cells (GCs) are critical in shaping the follicular development. To clarify how excessive androgen suppresses folliculogenesis and ovulation, we constructed PCOS mice by implantation of a 35-d testosterone (T) continuous-release pellet. Ovarian toll-like receptor 4 (TLR4) expression and serum IL-6 and IL-1β levels were dramatically increased in T-treated mice. In addition, the expression of NLRP3 inflammasome in the ovary of T-treated mice suggests that pyroptosis may play an essential role in follicular dysfunction. Lipopolysaccharide (LPS) has been extensively studied for activating cells by binding to TLR4. In this study, we demonstrated that LPS-induced inflammation leads to activation of the NLRP3 inflammasome with consequent impacts on follicular dysfunction. Herein we showed that LPS treatment upregulated the expression of 3β-hydroxysteroid dehydrogenase (3β-HSD) and androgen receptor (AR), while suppressed follicle stimulating hormone receptor (FSHR) expression in vitro. Moreover, we overexpressed NLRP3 using nigericin or lentiviral particles in GCs. The protein and mRNA levels of pyroptotic factors were highly enhanced with NLRP3 overexpression. As expected, the expression of Cyp19α1, Cyp11α1, 3β-HSD and FSHR at both the protein and mRNA levels was also markedly increased with excessive NLRP3. After inhibiting NLRP3, dihydrotestosterone (DHT)-treated GCs demonstrated markedly decreased NLRP3, the inflammasome adapter protein ASC, C-terminal fragment of gasdermin D (GSDMD-C), AR and Cyp19α1 at the protein level. Furthermore, with NLRP3 overexpression, the expression of fibrotic factors in ovarian cells was dramatically increased, such as TGF-β, CTGF, α-SMA, β-catenin, collagen I and collagen IV. These findings suggest that hyperandrogen stimulates chronic low-grade inflammation in the ovary to activate the NLRP3 inflammasome, further inducing a series of pathologies including ovarian GC pyroptotic death, follicular dysfunction and ovarian interstitial cell fibrosis.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibrosis; Follicular dysfunction; Hyperandrogenism; NLRP3; Pyroptosis

Mesh:

Substances:

Year:  2020        PMID: 32758727     DOI: 10.1016/j.scitotenv.2020.141049

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  20 in total

1.  Total glucosides of paeony inhibits liver fibrosis and inflammatory response associated with cirrhosis via the FLI1/NLRP3 axis.

Authors:  Jie Zhang; Yiwei Fu; Bin Yang; Xiaoxing Xiang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway.

Authors:  Fengping He; Yanhui Liu; Tang Li; Qiulin Ma; Zhang Yongmei; Peiqing He; Chuanyin Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway.

Authors:  Zhuang-Peng Chang; Gui-Feng Deng; Yun-Yun Shao; Ding Xu; Yi-Nan Zhao; Yi-Fan Sun; Shi-Quan Zhang; Rui-Gang Hou; Jun-Jin Liu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

4.  Identification of Bioactive Compounds and Potential Mechanisms of Kuntai Capsule in the Treatment of Polycystic Ovary Syndrome by Integrating Network Pharmacology and Bioinformatics.

Authors:  Xiushen Li; Jingxin Ma; Li Guo; Chenle Dong; Guli Zhu; Wenli Hong; Can Chen; Hao Wang; Xueqing Wu
Journal:  Oxid Med Cell Longev       Date:  2022-04-28       Impact factor: 7.310

5.  Elevated plasma pentraxin-3 in polycystic ovary syndrome is associated with hyperandrogenism: a case-control study.

Authors:  Congcong Jin; Kexin Zou; Yue Xu; Haiyan Yang; Jiexue Pan
Journal:  BMC Endocr Disord       Date:  2021-12-03       Impact factor: 2.763

6.  Curcumin in Combination with Aerobic Exercise Improves Follicular Dysfunction via Inhibition of the Hyperandrogen-Induced IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in PCOS-Like Rats.

Authors:  Yaling Zhang; Yajing Weng; Daojuan Wang; Rong Wang; Lihui Wang; Jianjun Zhou; Shanmei Shen; Hongwei Wang; Yong Wang
Journal:  Oxid Med Cell Longev       Date:  2021-12-26       Impact factor: 6.543

7.  Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer.

Authors:  Zeyu Zhang; Zhijie Xu; Yuanliang Yan
Journal:  Front Med (Lausanne)       Date:  2022-01-12

8.  Establishment and Mechanism Study of a Primary Ovarian Insufficiency Mouse Model Using Lipopolysaccharide.

Authors:  Si-Ji Lv; Shu-Hui Hou; Lei Gan; Jing Sun
Journal:  Anal Cell Pathol (Amst)       Date:  2021-11-16       Impact factor: 2.916

9.  The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment.

Authors:  Yishan Liu; Hao Liu; Zitao Li; Hualin Fan; Xiumin Yan; Xiao Liu; Jianyan Xuan; Du Feng; Xiangcai Wei
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 10.  Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites.

Authors:  Weixuan Chen; Yanli Pang
Journal:  Metabolites       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.